Low-Dose Maraviroc, an Antiretroviral Drug, Attenuates the Infiltration of T Cells into the Central Nervous System and Protects the Nigrostriatum in Hemiparkinsonian Monkeys-Reference-Cited by-同舟云学术

Low-Dose Maraviroc, an Antiretroviral Drug, Attenuates the Infiltration of T Cells into the Central Nervous System and Protects the Nigrostriatum in Hemiparkinsonian Monkeys

Published:2019-05-01 Issue:12 Volume:202 Page:3412-3422
ISSN:0022-1767
Container-title:The Journal of Immunology
language:en
Short-container-title:J.I.

Author:

Mondal Susanta,Rangasamy Suresh B.^ORCID,Roy Avik^ORCID,Dasarathy Sridevi^ORCID,Kordower Jeffrey H.,Pahan Kalipada^ORCID

Publisher

The American Association of Immunologists

Subject

Immunology,Immunology and Allergy

Reference55 articles.

1. Genetic clues to the pathogenesis of Parkinson's disease

2. ETIOLOGY AND PATHOGENESIS OF PARKINSON'S DISEASE

3. Parkinson's Disease

4. Neutralization of RANTES and Eotaxin Prevents the Loss of Dopaminergic Neurons in a Mouse Model of Parkinson Disease

5. Induction of Adaptive Immunity Leads to Nigrostriatal Disease Progression in MPTP Mouse Model of Parkinson’s Disease

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Blocking CCR5 activity by maraviroc augmentation in post-stroke depression: a proof-of-concept clinical trial;BMC Neurology;2024-06-06

2. CCR5 and inflammatory storm;Ageing Research Reviews;2024-04

3. The reciprocal interactions between microglia and T cells in Parkinson’s disease: a double-edged sword;Journal of Neuroinflammation;2023-02-12

4. Case series: Maraviroc and pravastatin as a therapeutic option to treat long COVID/Post-acute sequelae of COVID (PASC);Frontiers in Medicine;2023-02-08

5. Disease mechanisms as subtypes: Immune dysfunction in Parkinson's disease;Handbook of Clinical Neurology;2023